chartexchange

AMRN
Amarin Corp Plc
stockNASDAQADR

At CloseNov 13, 2026 3:59:52 PM EST
11.44USD-1.971%(-0.23)36,787
After-hoursNov 13, 2026 4:00:30 PM EST
11.38USD-0.524%(-0.06)
Loading…
Loading…
480.54M
Healthcare
Drug Manufacturers-General
CEO
John Thero
HQ
Dublin, Shelbourne Road Ballsbridge, Ireland
Previous Close
$11.67
Beta
0.50
52-Week High
$17.31 2026-01-23
52-Week Low
$11.25 2026-10-22
SMA 50
$12.58
SMA 200
$14.15
Avg. Vol 10D
93,739
Avg. Vol 30D
78,824
Avg. Vol 90D
69,678
Relative Vol
0.47
20.89M
0.3800%
1,000,000
Apr 11, 2025 · 1-for-20 (reverse)
AMRN Profile

amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.

AMRN Performance
PeriodPriceDateChangeBeta
1W11.612026-11-06-1.55%0.352
1M11.582026-10-13-1.29%1.094
3M14.152026-08-13-19.22%0.678
6M15.022026-05-13-23.90%0.416
1Y16.272025-11-13-29.75%0.498
2Y11.392024-11-13+0.35%—
5Y81.202021-11-12-85.92%1.084
AMRN Stock Summary

Amarin Corp Plc (NASDAQ:AMRN) stock price today is $11.43, and today's volume is 36,787. AMRN is down 2.057% today. The 30 day average volume is 78,824. AMRN market cap is $480.54M with 42.04M shares outstanding.